2022
DOI: 10.1002/ags3.12637
|View full text |Cite
|
Sign up to set email alerts
|

The impact of C‐reactive protein‐albumin‐lymphocyte (CALLY) index on the prognosis of patients with distal cholangiocarcinoma following pancreaticoduodenectomy

Abstract: Aim The C‐reactive protein (CRP)‐albumin‐lymphocyte (CALLY) index is a novel inflammation‐based biomarker, which has been associated with long‐term outcomes in patients with hepatocellular carcinoma. We aimed to investigate whether the CALLY index can predict the prognosis for distal cholangiocarcinoma after pancreaticoduodenectomy. Methods The study comprised 143 patients who had undergone primary pancreaticoduodenectomy for distal cholangiocarcinoma between 2002 to 20… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
7
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(7 citation statements)
references
References 22 publications
0
7
0
Order By: Relevance
“…Another investigation study including 1260 colorectal cancer cases reported that CALLY index was independently related to prognosis and had a higher clinical value 14 . Moreover, CALLY index was also significantly related to long-term outcomes in cholangiocarcinoma after surgery, suggesting the significant importance of comprehensive assessment of nutritional status and immune inflammatory response 15 . In addition, with an optimal cut-off value of 3.0, high CALLY index was related to better survival outcomes in those with epithelial ovarian cancer 16 .…”
Section: Discussionmentioning
confidence: 99%
“…Another investigation study including 1260 colorectal cancer cases reported that CALLY index was independently related to prognosis and had a higher clinical value 14 . Moreover, CALLY index was also significantly related to long-term outcomes in cholangiocarcinoma after surgery, suggesting the significant importance of comprehensive assessment of nutritional status and immune inflammatory response 15 . In addition, with an optimal cut-off value of 3.0, high CALLY index was related to better survival outcomes in those with epithelial ovarian cancer 16 .…”
Section: Discussionmentioning
confidence: 99%
“…The CALLY index, which is calculated from CRP and Alb re ecting in ammation, and lymphocyte counts re ecting immune function, was reported as an IBPS, and as a postoperative prognostic predictor for hepatocellular carcinoma [11]. The CALLY index is being increasingly reported as being associated with prognosis for various types of carcinomas [11][12][13][14]. In this study, compared to other IBPS, the CALLY index was an accurate prognostic indicator, and a low CALLY index was an independent poor prognostic factor for stage I-III CRC after curative resection.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, the C-reactive protein-albumin-lymphocyte (CALLY) index which is calculated from CRP, Alb, and lymphocyte counts drawn from blood examination results, was reported as a new in ammationbased prognostic scores (IBPS) [11]. As it is calculated from in ammatory responses and factors indicative of immune function, it is being increasingly reported as a prognostic indicator for various types of carcinomas [11][12][13][14]. However, a few studies have reported the effect of CALLY index on the prognosis of patients with CRC [15].…”
Section: Introductionmentioning
confidence: 99%
“…In combination, CRP, serum albumin, and lymphocyte levels may be more valuable and reliable biomarkers for predicting outcomes across various diseases, providing both inflammation level, nutritional status, and immune function information ( 33 , 34 ). Tsunematsu et al indicated that the CALLY index can predict long-term outcomes in patients with distal cholangiocarcinoma after pancreaticoduodenectomy, highlighting the importance of a comprehensive assessment of inflammatory status ( 67 ). Müller et al ( 68 ) found that the CALLY index was an independent prognostic predictor for overall survival in hepatocellular carcinoma (HCC) patients undergoing transarterial chemoembolization (TACE).…”
Section: Discussionmentioning
confidence: 99%